Stay updated with breaking news from Killer Engagers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
September 12, 2023 A new article, describing a set of affibody-based NK cell engagers using B cell maturation antigen as a model antigen for targeting of...
/PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat...
STOCKHOLM, Dec. 7, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (NASDAQ Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological
STOCKHOLM, Sept. 7, 2022 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological
/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq: ONCO) (Stockholm: ONCO), a biotech company focused on research and development of therapies for...